For Healthcare Professionals

Efficacy and Safety of MMFS in Early AD

clipboard-pencil

About the study

This study is designed to evaluate the safety and efficacy of MMFS for improving cognition and global function in patients with probable Early Alzheimer's disease.
pin location

Study Locations

Enter your ZIP code/Postal code/PIN code to locate study sites near you:

How to Apply


Contact the study center to learn if this study is a good match for you.

Study’s details


Age (in years)

55 - 85

Phase

Phase 2

Participants needed

12

Est. Completion Date

Mar 2020

Treatment type

Interventional


Sponsor

Neurocentria, Inc.

ClinicalTrials.gov identifier

NCT03531684

Study number

NC007

Understanding Clinical Trials


Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?
Vector

Interested?

Sign up to save your favorites, 
receive newsletters, resources, and alerts 
about clinical trials related to your conditions of interest.